Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
A spinoff company, Athira Pharma (formalized as M3 Biotechnology before rebranding), was founded in 2011 by PhD student Leen Kawas to commercialize dihexa and a related molecule, ATH-1017 (fosgonimeton)
These warning signs warrant immediate protocol review focusing on protein intake verification, training volume assessment, and caloric floor evaluation
The compound appears to exert bidirectional influence on the NO system: upregulating endothelial nitric oxide synthase (eNOS) expression in vascular endothelium while simultaneously attenuating the pathological overactivation of inducible nitric oxide synthase (iNOS) in inflammatory contexts
Potential Key Benefits*: Promotes increased energy and reduced fatigue Supports enhanced mental clarity and focus Promotes healthy aging processes Encourages improved cellular repair and function Supports better metabolic health Promotes DNA protection and cellular defense Made in America in a cGMP Facility Questions or Concerns
US$ 20.48
US$ 29.70
US$ 26.89
US$ 29.82
US$ 20.90
